Thursday, August 30, 2007

FlowCardia Garners $30M

Sunnyvale-based FlowCardia has raised $30M in a Series C round for its medical devices, the firm said Thursday. The funding round was led by Gilde Healthcare partners, and also included Life Sciences Partners, Hambrecht & Quist Capital Management LLC and New Science Ventures and existing investors Frazier Healthcare Ventures, JP Morgan Partners, Pappas Ventures, Rockport Venture Partners, and Gold Hill Capital. FlowCardia is developing medical devices for the treatment of coronary and peripheral chronic total occlusion. Arthur Franken, Fouad Azzam, and Frank Gentile of Hambrecht & Quist will join the firm's board as part of the funding. More information »